Literature DB >> 9565185

The prevalence of comorbid anxiety in schizophrenia, schizoaffective disorder and bipolar disorder.

S J Cosoff1, R J Hafner.   

Abstract

OBJECTIVE: The aim of this study to determine the prevalence of anxiety disorders in publically treated psychiatric inpatients with a DSM-IV diagnosis of schizophrenia, schizoaffective disorder or bipolar disorder.
METHOD: Using the Structured Clinical Interview for DSM-III-R (SCID), 100 consecutive inpatients with a psychotic disorder were examined for the presence or absence of an anxiety disorder. Questionnaire measures of phobias, obsessive-compulsive and general anxiety symptoms were also applied.
RESULTS: The prevalences of social phobia (17%), obsessive-compulsive disorder (13%) and generalised anxiety disorder in schizophrenia were relatively high, as were prevalences of obsessive-compulsive (30%) and panic disorder (15%) in bipolar disorder. The proportion of subjects with an anxiety disorder (43-45%) was almost identical across the three psychoses, with some evidence of gender differences. Although self-ratings of overall psychiatric symptoms were significantly elevated in those with anxiety disorders, hospital admission rates were not.
CONCLUSIONS: Almost none of those with anxiety disorders were being treated for them, primarily because the severity of the acute psychotic illness required full diagnostic and therapeutic attention. Patients were generally discharged as soon as their psychotic episode was resolved, with little recognition of the presence of an anxiety disorder. Given that anxiety disorders are relatively responsive to treatment, greater awareness of their comorbidity with psychosis should yield worthwhile clinical benefits.

Entities:  

Mesh:

Year:  1998        PMID: 9565185     DOI: 10.3109/00048679809062708

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  34 in total

Review 1.  Toward an integrative understanding of social phobia.

Authors:  D Li; P Chokka; P Tibbo
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

2.  Association of stigma, self-esteem, and symptoms with concurrent and prospective assessment of social anxiety in schizophrenia.

Authors:  Paul H Lysaker; Philip T Yanos; Jared Outcalt; David Roe
Journal:  Clin Schizophr Relat Psychoses       Date:  2010-04

3.  Co-morbid anxiety disorders in patients with schizophrenia in a tertiary institution in South East Nigeria: prevalence and correlates.

Authors:  Chinyere Aguocha; Kelechi Aguocha; Richard Uwakwe; Gabriel Onyeama
Journal:  Afr Health Sci       Date:  2015-03       Impact factor: 0.927

4.  Associations between comorbid anxiety, diabetes control, and overall medical burden in patients with serious mental illness and diabetes.

Authors:  Laura A Bajor; Douglas Gunzler; Douglas Einstadter; Charles Thomas; Richard McCormick; Adam T Perzynski; Stephanie W Kanuch; Kristin A Cassidy; Neal V Dawson; Martha Sajatovic
Journal:  Int J Psychiatry Med       Date:  2015-06-09       Impact factor: 1.210

5.  Levels of neurotrophic factors in the hippocampus and amygdala correlate with anxiety- and fear-related behaviour in C57BL6 mice.

Authors:  B K Yee; S-W Zhu; A H Mohammed; J Feldon
Journal:  J Neural Transm (Vienna)       Date:  2006-08-08       Impact factor: 3.575

6.  Anxiety disorders and rapid cycling: data from a cohort of 8129 youths with bipolar disorder.

Authors:  Ruby Castilla-Puentes; Regina Sala; Bernardo Ng; Juan Galvez; Alvaro Camacho
Journal:  J Nerv Ment Dis       Date:  2013-12       Impact factor: 2.254

Review 7.  How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association.

Authors:  Amélie M Achim; Michel Maziade; Eric Raymond; David Olivier; Chantal Mérette; Marc-André Roy
Journal:  Schizophr Bull       Date:  2009-12-03       Impact factor: 9.306

8.  Treatment of obsessive compulsive symptoms in schizophrenia with fluoxetine.

Authors:  V Agarwal; K M Agarwal
Journal:  Indian J Psychiatry       Date:  2000-07       Impact factor: 1.759

9.  Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia.

Authors:  Christoph U Correll; Christopher W Smith; Andrea M Auther; Danielle McLaughlin; Manoj Shah; Carmel Foley; Ruth Olsen; Todd Lencz; John M Kane; Barbara A Cornblatt
Journal:  J Child Adolesc Psychopharmacol       Date:  2008-10       Impact factor: 2.576

10.  Genetical Genomics of Behavior: A Novel Chicken Genomic Model for Anxiety Behavior.

Authors:  Martin Johnsson; Michael J Williams; Per Jensen; Dominic Wright
Journal:  Genetics       Date:  2016-01       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.